Overall Status

Completed (1)

Enrolling by invitation (1)

Recruiting (1)

Phase

phase 1 (1)

Sponsor

Columbia University (1)

Khondrion BV (1)

LMU Klinikum (1)

Collaborator

Drug Research Unit Ghent, Belgium (1)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

European Commission (1)

German Federal Ministry of Education and Research (1)

National Institutes of Health (NIH) (1)

University of Pisa (1)

Intervention

kh176 (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

lhon

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD Trial in Austria, Germany, Italy

Recruiting

Mitochondrial Diseases
+17 more

Innsbruck, Austria
+18 more

Sep 23, 2022

Tissue Sample Study for Mitochondrial Disorders

Enrolling by invitation

Mitochondrial Disorders
+8 more

New York, New York

Columbia University

Apr 4, 2022

MELAS, LHON, Leigh Syndrome Trial in Ghent (KH176, )

Completed

Has Results

MELAS
+4 more

KH176
placebo

Ghent, Belgium

Drug Research Unit Ghent

Oct 15, 2021